Clovis Oncology Articles

Another pancreatic cancer drug hits the dust - Clavis/Clovis' CP-4126

12 November 2012

Avila says Clovis selects clinical drug candidate; enters deal with NIAID for HCV candidate

9 June 2011

Pfizer pencils JV deal with Hisun for low-cost generics in China; out-licenses drug to Clovis

3 June 2011

Clavis Pharma and Clovis Oncology sign new $205 million deal for pancreatic cancer drug in Asia and rest of world

11 November 2010

Clovis Oncology and Avila Therapeutics enter $209 million partnership for EGFR mutant-selective inhibitor NSCLC candidate

26 May 2010

Showing 1-5 of 5 articles

Go to beginningPrevious
  • 1
NextGo to end